Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.11 +0.05 (+83.33%)
At close: Oct 1, 2026 · 4:00 PM EDT

Mosaic ImmunoEngineering (CPMV) Selling, General & Administrative (2010 - 2026)

Updated

Mosaic ImmunoEngineering (CPMV) posted Selling, General & Administrative of $138,922 for Q1 2026, down 12.6% from $158,971 a year earlier but up 5.2% from the prior quarter.

Analysis

Mosaic ImmunoEngineering (CPMV) Selling, General & Administrative (2010 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Selling, General & Administrative at Mosaic ImmunoEngineering was $532,089, down 18.6% year-over-year; for FY2025, it came in at $552,138, down 20.6% from FY2024.

  • Annual Selling, General & Administrative has declined for four consecutive years, though with a five-year compound annual growth rate of 2.3% (FY2020 to FY2025).
  • In prior years, Mosaic ImmunoEngineering's Selling, General & Administrative was $695,788 in FY2024 (-27.8%), $964,319 in FY2023 (-38.9%), $1.58 million in FY2022 (-22.8%) and $2.05 million in FY2021 (+314.9%).
  • Quarterly Selling, General & Administrative has run from a low of $128,319 in Q3 2025 to a high of $581,032 in Q2 2022 over five years.
  • On a year-over-year basis, Selling, General & Administrative has declined in each of the last 15 quarters, with an average decline of 21.1% over the last eight quarters.
  • The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q2 2022, with growth of 8.8%; the weakest was Q2 2023, with a decline of 60.4%.
  • According to Business Quant data, Selling, General & Administrative for the three prior quarters was $132,000 (Q4 2025), $128,319 (Q3 2025) and $132,848 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Mosaic ImmunoEngineering 796,635.07 796,635.07 - 138,922.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 138,922.00
Dec 31, 2025 132,000.00
Sep 30, 2025 128,319.00
Jun 30, 2025 132,848.00
Mar 31, 2025 158,971.00
Dec 31, 2024 133,907.00
Sep 30, 2024 146,831.00
Jun 30, 2024 213,595.00
Mar 31, 2024 201,455.00
Dec 31, 2023 225,629.00
Sep 30, 2023 226,944.00
Jun 30, 2023 229,868.00
Mar 31, 2023 281,878.00
Dec 31, 2022 290,532.00
Sep 30, 2022 306,124.00
Jun 30, 2022 581,032.00
Mar 31, 2022 401,377.00
Dec 31, 2021 431,681.00
Sep 30, 2021 521,131.00
Jun 30, 2021 533,935.00
API Access

Mosaic ImmunoEngineering Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CPMV&period=max&api_key=YOUR_API_KEY